O	3	6	The
O	7	11	risk
O	12	15	and
O	16	23	natural
O	24	30	course
O	31	33	of
B-Disease	34	37	age
I-Disease	37	38	-
I-Disease	38	45	related
I-Disease	46	57	maculopathy
O	57	58	:
O	59	65	follow
O	65	66	-
O	66	68	up
O	69	71	at
O	72	73	6
O	74	75	1
O	75	76	/
O	76	77	2
O	78	83	years
O	84	86	in
O	87	90	the
O	91	100	Rotterdam
O	101	106	study

O	108	118	Objectives
O	118	119	:
O	120	122	To
O	123	131	evaluate
O	132	135	the
O	136	143	natural
O	144	150	course
O	151	153	of
B-Disease	154	157	age
I-Disease	157	158	-
I-Disease	158	165	related
I-Disease	166	177	maculopathy
O	178	179	(
B-Disease	179	182	ARM
O	182	183	)
O	184	187	and
O	188	190	to
O	191	197	assess
O	198	201	the
O	202	211	incidence
O	212	215	and
O	216	224	absolute
O	225	229	risk
O	230	232	of
O	233	236	its
O	237	242	final
O	243	248	stage
O	248	249	,
B-Disease	250	253	age
I-Disease	253	254	-
I-Disease	254	261	related
I-Disease	262	269	macular
I-Disease	270	282	degeneration
O	283	284	(
B-Disease	284	287	AMD
O	287	288	)
O	288	289	.

O	291	298	Methods
O	298	299	:
O	300	302	In
O	303	304	a
O	305	315	population
O	315	316	-
O	316	321	based
O	322	333	prospective
O	334	340	cohort
O	341	346	study
O	347	349	of
O	350	354	6418
O	355	362	persons
B-Characteristic	363	365	55
I-Characteristic	366	371	years
I-Characteristic	372	375	and
I-Characteristic	376	381	older
O	381	382	,
O	383	385	we
O	386	393	studied
O	394	397	the
O	398	407	incidence
O	408	411	and
O	412	419	natural
O	420	426	course
O	427	429	of
B-Disease	430	433	ARM
O	433	434	.

O	435	443	Subjects
O	444	453	underwent
O	454	463	identical
O	464	476	examinations
O	476	477	,
O	478	487	including
B-Diagnostic_tool	488	500	stereoscopic
I-Diagnostic_tool	501	507	fundus
I-Diagnostic_tool	508	519	photography
O	519	520	,
O	521	523	at
O	524	532	baseline
O	533	536	and
O	537	539	at
O	540	541	2
O	541	542	.
O	542	543	0
O	544	547	and
O	548	549	6
O	549	550	(
O	550	551	1
O	551	552	/
O	552	553	2
O	553	554	)
O	555	560	years
O	560	561	'
O	562	568	follow
O	568	569	-
O	569	571	up
O	571	572	.

B-Disease	573	576	Age
I-Disease	576	577	-
I-Disease	577	584	related
I-Disease	585	596	maculopathy
O	597	600	was
O	601	607	graded
O	608	617	according
O	618	620	to
O	621	624	the
B-Classification_system	625	638	International
I-Classification_system	639	653	Classification
I-Classification_system	654	657	and
I-Classification_system	658	665	Grading
I-Classification_system	666	672	System
O	673	676	for
B-Disease	677	680	ARM
O	681	684	and
B-Disease	685	688	AMD
O	688	689	,
O	690	693	and
O	694	704	stratified
O	705	709	into
O	710	711	5
O	712	721	exclusive
O	722	728	stages
O	728	729	.

O	730	739	Incidence
O	740	743	was
O	744	753	expressed
O	754	756	in
O	757	762	rates
O	763	766	and
O	767	768	5
O	768	769	-
O	769	773	year
O	774	782	absolute
O	783	788	risks
O	788	789	.

O	791	798	Results
O	798	799	:
O	800	802	At
O	803	809	follow
O	809	810	-
O	810	812	up
O	812	813	,
O	814	816	47
O	817	820	new
O	821	826	cases
O	827	829	of
B-Disease	830	833	AMD
O	834	838	were
O	839	849	identified
O	849	850	,
O	851	855	with
O	856	857	a
O	858	863	ratio
O	864	866	of
B-Disease	867	878	neovascular
I-Disease	878	879	-
I-Disease	879	887	atrophic
I-Disease	888	891	AMD
O	892	894	of
O	895	896	1
O	896	897	.
O	897	898	4
O	898	899	:
O	899	900	1
O	900	901	.

O	902	905	The
O	906	907	5
O	907	908	-
O	908	912	year
O	913	917	risk
O	918	920	of
B-Disease	921	924	AMD
O	925	934	increased
O	935	939	with
O	940	944	more
O	945	951	severe
O	952	958	stages
O	959	961	to
O	962	964	28
O	964	965	.
O	965	966	0
O	966	967	%
O	968	971	for
O	972	980	subjects
B-Characteristic	981	983	55
I-Characteristic	984	989	years
I-Characteristic	990	993	and
I-Characteristic	994	999	older
O	1000	1004	with
B-Symptom	1005	1015	indistinct
I-Symptom	1016	1022	drusen
O	1023	1026	and
B-Symptom	1027	1037	pigmentary
I-Symptom	1038	1052	irregularities
O	1053	1054	(
B-Disease	1054	1059	stage
I-Disease	1060	1061	3
O	1061	1062	)
O	1062	1063	.

B-Characteristic	1064	1067	Age
O	1067	1068	,
O	1069	1072	but
O	1073	1076	not
B-Characteristic	1077	1080	sex
O	1080	1081	,
O	1082	1095	independently
O	1096	1105	increased
O	1106	1110	this
O	1111	1115	risk
O	1116	1118	to
O	1119	1120	a
O	1121	1128	maximum
O	1129	1131	of
O	1132	1134	42
O	1134	1135	.
O	1135	1136	0
O	1136	1137	%
O	1138	1141	for
O	1142	1150	subjects
O	1151	1155	with
B-Disease	1156	1161	stage
I-Disease	1162	1163	3
I-Disease	1164	1167	ARM
O	1168	1171	who
O	1172	1176	were
B-Characteristic	1177	1179	80
I-Characteristic	1180	1185	years
I-Characteristic	1186	1189	and
I-Characteristic	1190	1195	older
O	1195	1196	.

O	1197	1207	Individual
B-Disease	1208	1211	ARM
B-Symptom	1212	1218	fundus
I-Symptom	1219	1224	signs
O	1225	1229	that
O	1230	1239	predicted
O	1240	1244	best
O	1245	1248	the
O	1249	1260	development
O	1261	1263	of
B-Disease	1264	1267	AMD
O	1268	1272	were
B-Symptom	1273	1275	10
I-Symptom	1276	1278	or
I-Symptom	1279	1283	more
I-Symptom	1284	1289	large
I-Symptom	1290	1296	drusen
O	1297	1298	(
B-Dimension	1298	1299	>
I-Dimension	1300	1302	or
I-Dimension	1303	1304	=
I-Dimension	1304	1307	125
I-Dimension	1308	1314	microm
O	1314	1315	)
O	1316	1319	and
B-Symptom	1320	1322	10
I-Symptom	1322	1323	%
I-Symptom	1324	1326	or
I-Symptom	1327	1331	more
I-Symptom	1332	1334	of
I-Symptom	1335	1338	the
I-Symptom	1339	1343	grid
I-Symptom	1344	1348	area
I-Symptom	1349	1356	covered
I-Symptom	1357	1359	by
I-Symptom	1360	1366	drusen
O	1366	1367	.

O	1368	1376	Subjects
O	1377	1380	who
O	1381	1390	developed
B-Disease	1391	1399	atrophic
I-Disease	1400	1403	AMD
O	1404	1410	showed
O	1411	1413	no
O	1414	1425	significant
O	1426	1427	(
O	1427	1428	P
O	1429	1430	=
O	1430	1431	.
O	1431	1433	25
O	1433	1434	)
O	1435	1446	differences
O	1447	1449	in
O	1450	1458	baseline
B-Symptom	1459	1465	fundus
I-Symptom	1466	1471	signs
O	1472	1475	and
O	1476	1483	natural
O	1484	1490	course
O	1491	1499	compared
O	1500	1504	with
O	1505	1513	subjects
O	1514	1517	who
O	1518	1527	developed
B-Disease	1528	1539	neovascular
I-Disease	1540	1543	AMD
O	1543	1544	.

O	1546	1557	Conclusions
O	1557	1558	:
O	1559	1561	We
O	1562	1570	provided
O	1571	1574	the
O	1575	1583	absolute
O	1584	1588	risk
O	1589	1591	of
B-Disease	1592	1595	AMD
O	1596	1598	as
O	1599	1600	a
O	1601	1609	function
O	1610	1612	of
B-Characteristic	1613	1616	age
O	1617	1620	and
B-Symptom	1621	1626	early
I-Symptom	1627	1630	ARM
I-Symptom	1631	1637	fundus
I-Symptom	1638	1643	signs
O	1643	1644	,
O	1645	1648	and
O	1649	1655	showed
O	1656	1660	that
O	1661	1665	both
O	1666	1669	are
O	1670	1679	prominent
O	1680	1691	independent
O	1692	1696	risk
O	1697	1704	factors
O	1704	1705	.

O	1706	1709	The
O	1710	1721	progression
O	1722	1724	of
B-Disease	1725	1728	ARM
O	1729	1735	stages
O	1736	1743	follows
O	1743	1744	,
O	1745	1750	after
O	1751	1754	the
O	1755	1765	appearance
O	1766	1768	of
O	1769	1772	the
B-Symptom	1773	1778	first
I-Symptom	1779	1783	soft
I-Symptom	1784	1790	drusen
O	1790	1791	,
O	1792	1793	a
O	1794	1802	distinct
O	1803	1809	course
O	1810	1812	at
O	1813	1814	a
O	1815	1822	gradual
O	1823	1827	pace
O	1828	1832	that
O	1833	1844	accelerates
O	1845	1849	with
O	1850	1860	increasing
B-Characteristic	1861	1864	age
O	1864	1865	.
